We also uncover ERRα as a transcriptional regulator of Fbxw7 expression thus establishing a regulatory feedback loop, and further demonstrate the potential for pharmacological inhibition of uncontrolled ERRα activity to manage NASH. This evidence concerns the gene ESRRA and metabolic dysfunction-associated steatohepatitis.